Education
About Us
Working with TipRanks
Follow Us
China SXT Pharmaceuticals Inc (SXTC)
NASDAQ:SXTC
Total Valuation
China SXT Pharmaceuticals has a market cap or net worth of $21.75M. The enterprise value is ―.
Market Cap$21.75M
Enterprise Value―
Share Statistics
China SXT Pharmaceuticals has 13,763,268 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding13,763,268
Owned by Insiders―
Owned by Institutions0.44%
Financial Efficiency
China SXT Pharmaceuticals’s return on equity (ROE) is -0.22 and return on invested capital (ROIC) is -15.17%.
Return on Equity (ROE)-0.22
Return on Assets (ROA)-0.13
Return on Invested Capital (ROIC)-15.17%
Return on Capital Employed (ROCE)-0.18
Revenue Per Employee25.71K
Profits Per Employee-41.31K
Employee Count75
Asset Turnover0.08
Inventory Turnover1.70
Valuation Ratios
The current PE Ratio of China SXT Pharmaceuticals is -3.72. China SXT Pharmaceuticals’s PEG ratio is 0.04.
PE Ratio-3.72
PS Ratio0.69
PB Ratio0.83
Price to Fair Value0.83
Price to FCF-5.95
Price to Operating Cash Flow-5.97
PEG Ratio0.04
Income Statement
In the last 12 months, China SXT Pharmaceuticals had revenue of 1.93M and earned -3.10M in profits. Earnings per share was -3.57.
Revenue1.93M
Gross Profit553.97K
Operating Income-2.52M
Pretax Income-3.10M
Net Income-3.10M
EBITDA-2.35M
Earnings Per Share (EPS)-3.57
Cash Flow
In the last 12 months, operating cash flow was -1.93M and capital expenditures -7.06K, giving a free cash flow of -1.94M billion.
Operating Cash Flow-1.93M
Free Cash Flow-1.94M
Free Cash Flow per Share-0.14
Dividends & Yields
China SXT Pharmaceuticals pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.38
52-Week Price Change-72.74%
50-Day Moving Average3.02
200-Day Moving Average4.55
Relative Strength Index (RSI)49.51
Average Volume (3m)5.78M
Important Dates
China SXT Pharmaceuticals upcoming earnings date is Feb 1, 2021, TBA Not Confirmed.
Last Earnings DateMar 28, 2019
Next Earnings DateFeb 1, 2021
Ex-Dividend Date―
Financial Position
China SXT Pharmaceuticals as a current ratio of 1.60, with Debt / Equity ratio of 19.00%
Current Ratio1.60
Quick Ratio1.51
Debt to Market Cap0.21
Net Debt to EBITDA4.01
Interest Coverage Ratio-4.62
Taxes
In the past 12 months, China SXT Pharmaceuticals has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
China SXT Pharmaceuticals EV to EBITDA ratio is -0.89, with an EV/FCF ratio of -1.08.
EV to Sales1.09
EV to EBITDA-0.89
EV to Free Cash Flow-1.08
EV to Operating Cash Flow-1.09
Balance Sheet
China SXT Pharmaceuticals has $12.07M in cash and marketable securities with $2.65M in debt, giving a net cash position of -$9.42M billion.
Cash & Marketable Securities$12.07M
Total Debt$2.65M
Net Cash-$9.42M
Net Cash Per Share-$0.68
Tangible Book Value Per Share$16.04
Margins
Gross margin is 26.86%, with operating margin of -130.42%, and net profit margin of -160.67%.
Gross Margin26.86%
Operating Margin-130.42%
Pretax Margin-160.67%
Net Profit Margin-160.67%
EBITDA Margin-121.91%
EBIT Margin-132.45%
Analyst Forecast
The average price target for China SXT Pharmaceuticals is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―